Metabolic reprogramming in BC cells influences TAM differentiation, and increases glycolysis mediated by upregulation of hexokinase-2, PFK2 (ATP-dependent-6-phosphofructokinase), and enolase-1. The gene discussed is PFKFB3; the disease is breast cancer.